Skip to main content
BMC Immunology logoLink to BMC Immunology
. 2022 Aug 9;23:38. doi: 10.1186/s12865-022-00512-5

Correction: Thalidomide with blockade of costimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts

Maoshu Zhu 1,2,#, Yunhan Ma 3,4,#, Kai Tan 5, Liyi Zhang 3,4, Zhaowei Wang 1,2, Yongsheng Li 1,2, Yingyu Chen 3,4, Junjun Guo 3,4, Guoliang Yan 3,4,, Zhongquan Qi 3,4,6,
PMCID: PMC9361527  PMID: 35945504

Correction: BMC Immunol (2020) 21:19 10.1186/s12865-020-00352-1

Following publication of the original article [1], the author noticed an error in the funding number available in the Funding section. The funding number of the National Natural Science Foundation of China was incorrectly given as 81771271 and should have been 81771721.

The original article [1] has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Maoshu Zhu and Yunhan Ma contributed equally to this work and should share the first authorship

Contributor Information

Guoliang Yan, Email: zhuanyiyan@126.com.

Zhongquan Qi, Email: zqqi@xmu.edu.cn.

Reference

  • 1.Zhu M, et al. Thalidomide with blockade of costimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts. BMC Immunol. 2020;21:19. doi: 10.1186/s12865-020-00352-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Immunology are provided here courtesy of BMC

RESOURCES